Citation Impact
Citing Papers
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Conflicts of Interest and Disclosure in the American Psychiatric Association’s Clinical Practice Guidelines
2009 Standout
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
2011 Standout
Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics
2009
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
2016 Standout
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Attention‐Deficit‐Hyperactivity Disorder: An Update
2009
Oxidative stress, aging, and diseases
2018 Standout
Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: association with positive symptoms
2003
Global White Matter Abnormalities in Schizophrenia: A Multisite Diffusion Tensor Imaging Study
2009
Efficacy and safety of extract of Ginkgo biloba as an adjunct therapy in chronic schizophrenia: A systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis
2015
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine
2002
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
2007
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia
2001
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
2007 Standout
ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage
2002
Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier
2001
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Hypersexual Disorder: A Proposed Diagnosis for DSM-V
2009 Standout
The Effect of Risperidone Treatment on Superoxide Dismutase in Schizophrenia
2003
Antioxidants as potential therapeutics for neuropsychiatric disorders
2012
Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia
2005
Importance of oxidative stress in the pathogenesis, diagnosis, and monitoring of patients with neuropsychiatric disorders, a review
2021
Omega-3 fatty acids and neuropsychiatric disorders
2005
The role of mitochondrial dysfunction in psychiatric disease
2010
A preliminary, randomized, double-blind, placebo-controlled trial of l-carnosine to improve cognition in schizophrenia
2012
Oxidative Stress and Psychological Disorders
2014
Oxidative stress and cell cycle checkpoint function11Both Drs. Paules and Kaufmann received their doctoral degrees in Experimental Pathology from the University of North Carolina at Chapel Hill School of Medicine (in 1984 and 1979, respectively).
2000
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Fish Intake, Contaminants, and Human Health
2006 Standout
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
2012 Standout
Free radicals, antioxidant defense systems, and schizophrenia
2013
Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function
2004
The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy
2004 Standout
Vitamin C in Disease Prevention and Cure: An Overview
2013
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
2008
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
The acute effects of NMDA antagonism: From the rodent to the human brain
2008
Reliability of malondialdehyde as a biomarker of oxidative stress in psychological disorders
2015
Lipid peroxidation in patients with schizophrenia
2010
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
The Influence of Exercise on Cognitive Abilities
2012 Standout
Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
2009 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Pharmacotherapy of Children and Adolescents with Bipolar Disorder
2005
Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia
2003
Large-scale brain networks and psychopathology: a unifying triple network model
2011 Standout
Oxidative Damage and Schizophrenia
2001
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
Neurodevelopmental Outcomes of Very Low-Birth-Weight Infants With Necrotizing Enterocolitis
2007
Recovery of microalgal biomass and metabolites: process options and economics
2002 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Assessing mitochondrial dysfunction in cells
2011 Standout
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
2014 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Chapter 4European guidelinesfor the management of chronicnonspecific low back pain
2006 Standout
Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple
2001 Standout
Cultivation, Genetic, Ethnopharmacology, Phytochemistry and Pharmacology of Moringa oleifera Leaves: An Overview
2015 Standout
Invited Review: Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their Quantification
2002 Standout
Recent developments in the epidemiology of bipolar disorder in adults and children: Magnitude, correlates, and future directions.
2009
Reduced expression of the ferroptosis inhibitor glutathione peroxidase‐4 in multiple sclerosis and experimental autoimmune encephalomyelitis
2018
Nitric oxide as a physiopathological factor in neuropsychiatric disorders.
2005
Works of Russell E. Scheffer being referenced
Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis
1994
Oxidative injury and potential use of antioxidants in schizophrenia
1996
Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls
1996
Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis
1998
Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects
1996
Randomized, Placebo-Controlled Trial of Mixed Amphetamine Salts for Symptoms of Comorbid ADHD in Pediatric Bipolar Disorder After Mood Stabilization With Divalproex Sodium
2004
Early relapse after recovery from a first episode of psychosis: Possible role of oxidative stress
1995
Concurrent medical conditions with pediatric bipolar disorder
2007
Impaired antioxidant defense at the onset of psychosis
1996
Elevated levels of lipid peroxidation products in plasma of drug-naive patients at the onset of psychosis
1995
Mitogenic response to basic fibroblast growth factor (BFGF) in cultured skin fibroblasts from first episode psychosis patients
1995
The antioxidant defense system at the onset of psychosis
1994